Faculty Portal

Ms. Kamini Sethy

M.Pharm

Assistant Professor

School of Pharmacy and Life Sciences

Department: NA

Phone: 6370184717

About Me
I am working as an Assistant Professor in school of pharmacy, CUTM, Rayagada since 1st august, 2019. I have 11 years of academic experience.

Research Fields

Pharmaceutical Analysis

Teaching

Biochemistry

Pharmaceutical inorganic Chemistry

Pharmaceutical organic Chemistry

Medicinal chemistry

Expertise

Spectroscopy

Liquid chromatography

Interests

Pharmaceutical and Phytopharmaceutical drug analysis

Analytical method development & validation in bulk drug & marketed formulation.

Sl. No.	Title	Issuer

Publicaion 1

Delamanid and bedaquiline – A review on analytical methods determined with recent updates on pharmacokinetics, pharmacodynamics, and drug-drug interaction

Publisher: Thai Journal of Pharmaceutical Sciences

Volume:

ISBN: 2

Date of Publish: 2024-02-10

Author: Kamini Sethy, K. Raja Rajeswari, Gopal Krishna Padhy

Description:

Publicaion 2

A green reversed phase HPLC and HPTLC methods and their validation for simultaneous estimation of remogliflozin, vildgliptin and metformin in fixed dose combination formulation

Publisher: Taylor & Francis

Volume:

ISBN:

Date of Publish: 2023-12-04

Author: Kamini Sethy, Gopal Krishna Padhy & Raja Rajeswari Katta

Description:

Publicaion 3

A New HPLC Stability Indicating Method and Validation for Simultaneous Quantitation of Bilastine and Montelukast Sodium in API and Marketed Formulation by QbD Approach

Publisher: Asian Publication Corporation

Volume:

ISBN: 7

Date of Publish: 2022-06-15

Author: Kamini Sethy, K. Raja Rajeswari, Gopal Krishna Padhy

Description:

Faculty Portal | CUTM

Research Fields

Recent Publications (International Journals)

Academic Honors & Awards

Delamanid and bedaquiline – A review on analytical methods determined with recent updates on pharmacokinetics, pharmacodynamics, and drug-drug interaction

A green reversed phase HPLC and HPTLC methods and their validation for simultaneous estimation of remogliflozin, vildgliptin and metformin in fixed dose combination formulation

A New HPLC Stability Indicating Method and Validation for Simultaneous Quantitation of Bilastine and Montelukast Sodium in API and Marketed Formulation by QbD Approach